Study Information

Title: A Phase 1 Study Evaluating CPI-0610 in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelodysplastic/Myeloproliferative Neoplasms External
Status: Recruiting participants
Conditions: Acute Leukemia (AML); Myelodysplastic Syndrome (MDS); Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)
Interventions: Drug: CPI-0610
Institutions: Massachusetts General Hospital
Health Topics: Myelodysplastic Syndromes

Contact Information


Massachusetts General Hospital
Boston, MA 02114
Amir Fathi, MD
617-724-1124
afathi@partners.org